This report describes a pair of identical twins with IgA nephropathy (IgAN). One of them showed diffuse mesangial proliferation with crescent formations in the glomeruli, moderate proteinuria and required intensive therapies including corticosteroids for remission. In contrast, the other had only focal mesangial alterations and exhibited only a subtle level of urinary abnormalities throughout the follow-up without steroid therapy. Although our monozygotic twins have completely identical genotypes, the clinicopathological features of their IgAN were quite discordant. The present cases suggest that not only genetic factors but also epigenetic differences may be involved in the progression of IgAN.
Introduction
Studies of multiplex affected families or case-control associations with certain gene polymorphisms have suggested that there are genetic components in the pathogenesis of IgA nephropathy (IgAN) [1] . Identical twins represent a powerful resource for revealing multifactorial mechanisms in human diseases, especially in those in whom both genetic and environment factors may play roles, such as in IgAN. To the best of our knowledge, however, only one pair of twins with IgAN, who showed similar phenotypes as IgAN, have so far been reported [2] . We herein report an interesting pair of monozygotic identical twins with IgAN who showed discordant clinicopathological features.
Case report

Case 1
The patient was a 24-year-old female office worker without any remarkable medical history other than microscopic hematuria and proteinuria which were observed at the age of 16 years. There was no familial history of kidney diseases, except for her twin sister who also had proteinuria and hematuria. The patient was referred to our hospital 8 years after the onset of urinary abnormalities.
The clinical features of the patient are summarized in Table  1 . At the time of diagnosis, routine blood examinations and the levels of serum immunoglobulins and complement factors were within normal ranges. All other serological findings were negative or normal. In the urinary sediments, there were 10-29 red blood cells/high power field (hpf) and granular casts and red blood cell casts were detected. The urinary protein excretion (UPE) and the 24-h creatinine clearance (Ccr) were 2.82 g/day and 153 mL/min, respectively. The size of kidneys was determined to be normal using an ultrasound.
A renal biopsy showed diffuse proliferative glomerulonephritis with crescent formations, which was comparable with the active form of IgAN (Table 2) . She was given an intravenous methylprednisolone (mPSL; 500 mg/day) pulse for three consecutive days and then received at an initial dose of 30 mg/day prednisolone (PSL) orally. Losartan (50 mg/day) and lisinopril (10 mg/day) were sequentially started, and warfarin (1 mg/ day) and dypiridamole (300 mg/day) were also added. The levels of UPE tended to decrease but remained 0.5-1.0 g/day. Microscopic hematuria was constantly detected. Twenty-four months after the first biopsy, a repeated renal biopsy was performed (Table 2) .
Since the second renal biopsy, findings still showed active lesions and additional immunosuppressive therapies were considered. A tonsillectomy was carried out and another intravenous mPSL pulse (500 mg/day, for three consecutive days) was performed three times every 2 months. Meanwhile, 20 mg (0.5 mg/kg/day) of oral PSL was administered every other day. Under this treatment, the UPE was reduced to 0.2-0.5 g/day and the degree of microscopic hematuria was also decreased.
Case 2
The patient was a female professional painter without any particular medical history. She was the identical twin sister of the patient described as Case 1. When she was 15 years old, she was first noted to have microscopic hematuria. When she was 16 years old, she was noted to have proteinuria in addition to the microscopic hematuria. Because her twin sister had been diagnosed with IgAN, she was referred to our hospital for a checkup 10 years after the onset of her urinary abnormalities.
The clinical features of Case 2 are summarized in Table 1 . At the time of diagnosis, her routine laboratory examinations indicated that all of her values were within the normal ranges. In her urinary sediments, there were 5-9 red blood cells/high power field and neither granular casts nor red blood cell casts were detected. The UPE and the 24-h Ccr were 0.45 g/day and 181 mL/min, respectively.
The renal biopsy findings showed focal proliferative glomerulonephritis with mesangial IgA deposits ( Table  2) . Treatment with dypiridamole (300 mg/day) was started. After discharge, the patient's UPE remained 0.2-0.3 g/day throughout the observation period.
Monozygosis of Case 1 and Case 2 was determined after giving informed consent by analyzing the following polymorphic microsatellites at different chromosomes: D8S1179, D21S11, D7S820, CSF1PO, D3S1358, TH01, D13S317, D16S539, D2S1338, D19S433, vWA, TPOX, D18S51, D5S818, FGA, Amelogenin (Genetrack Biolabs Inc., Vancouver, Canada).
Discussion
In the present cases, the estimated age at onset was almost the same and the degrees and patterns of glomerular IgA depositions in biopsies were similar. However, only the elder twin (Case 1) showed a severe phenotype of IgAN, which was indicated by the more advanced renal tissue injuries and the larger amount of maximal or time-averaged proteinuria during the follow-up [3] . As a result, only the elder twin needed a series of aggressive therapies in order to achieve remission, including the use of corticosteroid. Our present cases therefore suggest the possibility that the initial trigger of IgAN is, at least in some cases, attributed by the genetic background. However, our cases also suggest that the clinicopathological severities of IgAN are likely defined by the yet unknown non-genetic factors, which are also independent of glomerular IgA deposition.
There have been some case reports of identical twins with glomerular diseases other than IgAN that showed discordant clinicopathological features [4] [5] [6] . One of the The blood pressure and urinary protein excretion during the follow-up was averaged and are shown as the time-averaged mean arterial pressure and timeaveraged proteinuria, respectively (means 6 SD). several possible explanations for such observations may be the existence of epigenetic differences, which can be influenced by external factors, such as physical activity or diet [7, 8] . In our cases, however, such differences in eating habits or body size were not apparent. Interestingly, however, the elder twin, who showed the relatively severe phenotype, seemed to be clinically attenuated after a tonsillectomy, which was carried out together with the second regimen of corticosteroid. To resolve some of the concerns related to the pathogenesis of IgAN, further investigations will be required, especially those focusing on the epigenetic differences, such as those due to the interaction between mucosal immunity and microorganisms [9] .
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